Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02753075 · ClinicalTrials.gov registry record · NA

A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.

A NA study of Dentin Sensitivity, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT02753075 is a NA study of Dentin Sensitivity that has completed, run by GlaxoSmithKline. The registered enrollment target is 240 participants, above the 197-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02753075, a NA study of Dentin Sensitivity, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the longitudinal efficacy of two experimental oral rinses, one containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX) /0 Parts per Million (ppm fluoride) and the other 2.0% w/w KOX /45ppm fluoride, for the relief of dentinal hypersensitivity (DH), compared to a placebo oral rinse, when used as an adjunct to twice daily brushing with a standard fluoride toothpaste.

Conditions Studied

Interventions

  • DEVICE Experimental Oral Rinse 1
  • DEVICE Experimental Oral Rinse 2
  • OTHER Placebo Oral Rinse
  • DRUG Fluoride toothpaste

Study Locations (1)

Indiana

  • GSK Investigational Site - Fort Wayne

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2015-09-08
Est. Completion 2015-12-18
Phase NA

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT02753075

The ClinicalTrials.gov registry entry for NCT02753075 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 197-participant average among 3 other Dentin Sensitivity trials with a reported enrollment target (22% higher). The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dentin Sensitivity appearing as the primary indexed condition, and to 4 interventions - of which Experimental Oral Rinse 1 is the first listed.

NCT02753075 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02753075 about?

NCT02753075 is a clinical study titled "A Study in Dentinal Hypersensitivity (DH) Participants to Assess the Efficacy of an Occluding Dentifrice.". This study will investigate the longitudinal efficacy of two experimental oral rinses, one containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX) /0 Parts per Million (ppm fluoride) and the other 2.0% w/w KOX /45ppm fluoride, for the relief of dentinal hypersensitivity (DH), compa...

What is the current status of trial NCT02753075?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2015-09-08. Estimated completion is 2015-12-18.

What conditions does trial NCT02753075 study?

This clinical trial studies the following conditions: Dentin Sensitivity.

What interventions are being tested in trial NCT02753075?

The interventions under investigation include: Experimental Oral Rinse 1 (DEVICE), Experimental Oral Rinse 2 (DEVICE), Placebo Oral Rinse (OTHER), Fluoride toothpaste (DRUG).

Who is sponsoring clinical trial NCT02753075?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02753075 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dentin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.